HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Beibei Yin Selected Research
Beibei Yin Research Topics
Disease
7
Neoplasms (Cancer)
01/2022 - 11/2012
4
Lung Neoplasms (Lung Cancer)
02/2018 - 04/2012
2
Carcinoma (Carcinomatosis)
02/2018 - 08/2016
2
Hypoxia (Hypoxemia)
02/2018 - 08/2016
2
Genetic Predisposition to Disease (Genetic Predisposition)
02/2013 - 04/2012
1
Triple Negative Breast Neoplasms
01/2021
1
Breast Neoplasms (Breast Cancer)
01/2021
1
Fatigue
01/2020
1
Cough
01/2020
1
Pneumonia (Pneumonitis)
01/2020
1
Disease Progression
01/2020
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1
Organizing Pneumonia
01/2020
1
Ovarian Neoplasms (Ovarian Cancer)
10/2019
1
Stomach Neoplasms (Stomach Cancer)
01/2015
1
Inflammation (Inflammations)
02/2013
1
Adenocarcinoma
11/2012
1
Brain Neoplasms (Brain Tumor)
11/2012
1
Neoplasm Metastasis (Metastasis)
11/2012
Drug/Important Bio-Agent (IBA)
3
Immune Checkpoint Inhibitors
IBA
01/2022 - 01/2020
3
pembrolizumab
IBA
01/2022 - 01/2020
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
02/2018 - 04/2012
3
Interleukin-6 (Interleukin 6)
IBA
02/2018 - 02/2013
2
atezolizumab
IBA
01/2022 - 01/2021
2
Docetaxel (Taxotere)
FDA Link
10/2019 - 01/2015
2
Interferons
IBA
02/2018 - 08/2016
2
Interleukin-17 (Interleukin 17)
IBA
02/2018 - 08/2016
2
Interleukin-10 (Interleukin 10)
IBA
02/2018 - 08/2016
2
Interleukins
IBA
02/2018 - 08/2016
2
Endostatins
IBA
02/2018 - 08/2016
2
Biomarkers (Surrogate Marker)
IBA
02/2013 - 04/2012
1
avelumab
IBA
01/2022
1
Ipilimumab
IBA
01/2022
1
cemiplimab
IBA
01/2022
1
Programmed Cell Death 1 Receptor
IBA
01/2022
1
durvalumab
IBA
01/2022
1
Nivolumab
IBA
01/2022
1
Platinum
IBA
01/2020
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
02/2018
1
Phosphates (Orthophosphate)
IBA
08/2016
1
Transforming Growth Factors (Transforming Growth Factor)
IBA
08/2016
1
Enzymes
IBA
08/2016
1
Neoplasm Antigens (Tumor Antigens)
IBA
08/2016
1
Therapeutic Uses
IBA
01/2015
1
Stathmin
IBA
01/2015
1
Oligodeoxyribonucleotides
IBA
01/2015
1
Cytokines
IBA
02/2013
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
02/2013
1
Cisplatin (Platino)
FDA Link
Generic
11/2012
1
Pemetrexed (MTA)
FDA Link
11/2012
Therapy/Procedure
4
Therapeutics
01/2021 - 11/2012
3
Drug Therapy (Chemotherapy)
01/2021 - 11/2012
2
Immunotherapy
01/2022 - 01/2021
1
Subcutaneous Injections
08/2016